These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 12784502)

  • 1. Individualization of drug dosage--past, present and future.
    Thomson AH
    Med Monatsschr Pharm; 2003 May; 26(5):150-2. PubMed ID: 12784502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Individualization of drug therapy: history, present state, and opportunities for the future.
    Lesko LJ; Schmidt S
    Clin Pharmacol Ther; 2012 Oct; 92(4):458-66. PubMed ID: 22948891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Individualization of drug dosage regimens.
    Platt DR
    Clin Lab Med; 1987 Jun; 7(2):289-99. PubMed ID: 3301171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tailor-made drug treatment for children: creation of an infrastructure for data-sharing and population PK-PD modeling.
    Ince I; de Wildt SN; Tibboel D; Danhof M; Knibbe CA
    Drug Discov Today; 2009 Mar; 14(5-6):316-20. PubMed ID: 19059496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Role of pharmacokinetic-pharmacodynamic relationships in drug development].
    Bellissant E; Courcier-Duplantier S; Blin O;
    Therapie; 2002; 57(4):347-57. PubMed ID: 12422555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Therapeutic monitoring of drugs as a real progress in drug therapy].
    Hermann TW
    Wiad Lek; 1992 Jan; 45(1-2):73-9. PubMed ID: 1295246
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmacokinetic-pharmacodynamic relationship.
    Baggot JD
    Ann Rech Vet; 1990; 21 Suppl 1():29S-40S. PubMed ID: 2080844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current concepts in pharmacokinetics and their implications for clinical medicine.
    Müller M; Müller-Zellenberg U; Hochhaus G; Derendorf H
    Wien Klin Wochenschr; 2001 Aug; 113(15-16):566-72. PubMed ID: 11571833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Population approaches in paediatrics.
    Chatelut E
    Fundam Clin Pharmacol; 2008 Dec; 22(6):575-8. PubMed ID: 19049657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug dosage individualization based on a random-effects linear model.
    Diaz FJ; Cogollo MR; Spina E; Santoro V; Rendon DM; de Leon J
    J Biopharm Stat; 2012; 22(3):463-84. PubMed ID: 22416835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integration and modelling of pharmacokinetic and pharmacodynamic data to optimize dosage regimens in veterinary medicine.
    Toutain PL; Lees P
    J Vet Pharmacol Ther; 2004 Dec; 27(6):467-77. PubMed ID: 15601441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug development perspective on pharmacokinetic studies of new drugs in patients with renal impairment.
    Lalonde RL; Wagner JA
    Clin Pharmacol Ther; 2009 Nov; 86(5):557-61. PubMed ID: 19776736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Customizing dosage drugs what contribution in therapeutic drug monitoring?].
    Abdessadek M; Magoul R; Amarti A; El Ouezzani S; Khabbal Y
    Ann Biol Clin (Paris); 2014; 72(1):15-24. PubMed ID: 24492095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantifying the Effectiveness of Dose Individualization by Simulation for a Drug With Moderate Pharmacokinetic Variability.
    Liefaard L; Chen C
    Ther Drug Monit; 2015 Oct; 37(5):641-8. PubMed ID: 26378372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative pharmacology or pharmacokinetic pharmacodynamic integration should be a vital component in integrative pharmacology.
    Gabrielsson J; Green AR
    J Pharmacol Exp Ther; 2009 Dec; 331(3):767-74. PubMed ID: 19779129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Principles of therapeutic drug monitoring].
    Widmer N; Csajka C; Werner D; Grouzmann E; Decosterd LA; Eap CB; Biollaz J; Buclin T
    Rev Med Suisse; 2008 Jul; 4(165):1644-8. PubMed ID: 18767290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Individualized drug and dose: the clinical pharmacologist's calling or curse?
    Begg EJ
    Clin Exp Pharmacol Physiol; 2005 Nov; 32(11):975-8. PubMed ID: 16405455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacodynamic aspects of modes of drug administration for optimization of drug therapy.
    Hoffman A; Stepensky D
    Crit Rev Ther Drug Carrier Syst; 1999; 16(6):571-639. PubMed ID: 10677802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Applications of population pharmacokinetics in current drug labelling.
    Duan JZ
    J Clin Pharm Ther; 2007 Feb; 32(1):57-79. PubMed ID: 17286790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.